Researchers found that metabolic syndrome was associated with lower neurocognitive function, particularly among middle-aged adults.
Women who have a later natural menopause maintain a small benefit in verbal memory compared with women with earlier menopause.
The type of sciatic nerve lesions observed in patients with diabetic peripheral neuropathy was found to differ in type 1 and type 2 diabetes.
Young adults with type 1 diabetes have altered neural responses during working memory processing.
Further research is warranted to clarify the role played by insulin resistance in the pathogenesis of amyotrophic lateral sclerosis.
Study provides stronger epidemiological evidence for obesity as a risk factor for diabetic polyneuropathy.
Researchers assessed the effects of 2 frequently used formulations of menopausal hormone therapy on brain structure and cognition 3 years after the completion of a randomized clinical trial.
Researchers assessed whether retinal vascular signs were associated with greater cognitive decline over 20 years.
Testosterone levels were increased in women with stable multi-episode schizophrenia and decreased in men with stable multi-episode schizophrenia.
Oral vitamin E supplementation consisting of 400 mg/day mixed tocotrienols for 1 year may not result in improved neuropathic pain symptoms in patients with diabetic peripheral neuropathy.
A recent study assessed the affiliation between HbA1c level, diabetes prominence, and successive decline of cognition during a 10-year span.
The Food and Drug Administration has accepted the New Drug Application for Azedra for the treatment of malignant, recurrent and/or unresectable pheochromocytoma and paraganglioma.
The relationship between hormones and migraine is most frequently pronounced during the female reproductive years.
For patients with panic disorder with agoraphobia, cortisol mediates the effect of the time of day on subsequent outcome.
For patients with hypertension and obstructive sleep apnea, treatment with losartan does not lead to significant reductions in aldosterone, but the treatment is tied to aldosterone reductions in patients with hypertension but without obstructive sleep apnea.
An experimental study found a sex-specific role in glucose-dependent control of autonomic nervous activity.
Younger patients with type 2 diabetes had significant differences in brain gray matter volume compared with healthy controls.
For participants without obesity, striatal D2 receptor (D2R) binding potential and age are associated with sucrose preference.
Gastric bypass surgery is associated with reduced symptoms and neurohormonal responses to hypoglycemia, according to a study published in Diabetes.
The findings suggest a neuroendocrine vulnerability in women with migraine.
A new instrument may provide physicians insight into satisfaction with acromegaly treatment.
Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.
Phthalate exposure effect explained half of the attention deficit in children treated in the ICU.
The presence of a pituitary tumor on magnetic resonance imaging confirmed the diagnostic hypothesis.
Insulin resistance may underlie some cases, researchers said.
Two genetic variants are associated with heightened brain reward responses to foods high in fat and sugar.
New data link hypothalamic gliosis with higher BMI and increased insulin resistance.
Noninvasive brain stimulation may help decrease caloric intake and promote weight loss.
Hypothalamic-sympathetic nervous system-renal axis has been identified that regulates tubular glucose reabsorption.
In type 2 diabetes, improving glycemic control may decrease dementia risk.
Endocrinology Advisor Articles
- Predictors of Success for Insulin-to-Liraglutide Switch for Type 2 Diabetes
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Pre-Pregnancy Programs May Improve Outcomes in Women With Type 2 Diabetes
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- IV Fluid Infusion Rates Do Not Affect Pediatric DKA Neurologic Outcomes
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Psychiatric Morbidity Decreased After Assisted Reproductive Technology Treatment
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk